Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

20.20
Delayed Data
As of Dec 09
 +0.15 / +0.75%
Today’s Change
12.25
Today|||52-Week Range
27.02
+11.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues111.2M104.8M116.7M110.5M
 
 
 
 
 
Cost of Goods Sold20.3M19.9M20.3M19.6M
 
 
 
 
 
Depreciation And Amortization27.8M27.7M27.7M27.7M
 
 
 
 
 
 
Operating ExpensesGross Income63.1M57.2M68.7M63.2M
 
 
 
 
 
General Expenses64.7M58.7M59.1M61.9M
 
 
 
 
 
Research And Development6.3M5.9M7.1M10.4M
 
 
 
 
 
Total Operating Expenses112.7M106.3M107.1M109.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.6M-1.5M9.6M1.3M
 
 
 
 
 
Extraordinary Credit29.9M177.0K110.0K0.00
 
 
 
 
Extraordinary Charge-54.9M-3.6M-6.4M-686.0K
 
 
 
 
 
Interest Expense On Debt22.7M22.1M19.5M19.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-48.9M-26.9M-16.2M-18.9M
 
 
 
 
 
Income Taxes-18.2M-6.0M-5.7M-6.0M
 
 
 
 
 
Net Income-30.7M-20.9M-10.5M-12.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS60.6M60.9M61.2M61.4M
 
 
 
 
 
Shares To Calculate EPS Diluted60.6M60.9M61.2M61.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.51-$0.34-$0.17-$0.21
 
 
 
 
 
EPS Diluted-$0.51-$0.34-$0.17-$0.21